Lurasidone HCl

FDA Drug Profile

Lurasidone HCl is listed in the FDA National Drug Code directory with 2 NDC codes. Available dosage form: powder.

Drug details

Generic Name
Lurasidone HCl
Sponsor
Veranova, L.P.
NDC Codes
2
Dosage Forms
POWDER
Active Ingredients
LURASIDONE HYDROCHLORIDE

Indications and Usage

Lurasidone hydrochloride tablets are indicated for: Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see Clinical Studies (14.1)]. Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)]. Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Clinical Studies (14.2)].

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.